India faces a signifcant diabetes epidemic, with approximately 72 million people  diagnosed with diabetes and an additional 80 million in the pre-diabetes stage. Type  2 Diabetes accounts for over 90-95% of all diabetes cases in India. Managing Glycemic
variability (GV) is essential to prevent complications and improve patient outcomes.  GV is a critical aspect of diabetes management, and its signifcance in type 2 diabetes is  increasingly recognized in India, where the prevalence of diabetes is rapidly growing.1-4
GV refers to the fluctuations in glucose values around the baseline, and high GV is  associated with a higher risk of diabetes associated complications.1,2